Matches in Nanopublications for { ?s ?p "[GSTM1 deletion is significantly associated with the increased risk of symptomatic BPH, but none of the GST polymorphisms appears associated with response to standard BPH therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_assertion description "[GSTM1 deletion is significantly associated with the increased risk of symptomatic BPH, but none of the GST polymorphisms appears associated with response to standard BPH therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_provenance.
- NP438545.RAcFj14v3t968zJDiJ37OqV1Q7ZJrrfC05HmTOdATJjOQ130_assertion description "[GSTM1 deletion is significantly associated with the increased risk of symptomatic BPH, but none of the GST polymorphisms appears associated with response to standard BPH therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438545.RAcFj14v3t968zJDiJ37OqV1Q7ZJrrfC05HmTOdATJjOQ130_provenance.
- NP857102.RA_FulFajmyJygxk9VspUYhyliF5-iH2FM3mupPmuWodQ130_assertion description "[GSTM1 deletion is significantly associated with the increased risk of symptomatic BPH, but none of the GST polymorphisms appears associated with response to standard BPH therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857102.RA_FulFajmyJygxk9VspUYhyliF5-iH2FM3mupPmuWodQ130_provenance.